Proteína hidrolisada de aves e suínos em dietas para alevinos (tilápia do Nilo): desempenho produtivo e sobrevivência

Detalhes bibliográficos
Ano de defesa: 2020
Autor(a) principal: Santos, Adriano José Führ dos lattes
Orientador(a): Boscolo, Wilson Rogério lattes
Banca de defesa: Boscolo, Wilson Rogério lattes, Bittencourt, Fábio lattes, Silva, Lilian Carolina Rosa da lattes
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Estadual do Oeste do Paraná
Toledo
Programa de Pós-Graduação: Programa de Pós-Graduação em Recursos Pesqueiros e Engenharia de Pesca
Departamento: Centro de Engenharias e Ciências Exatas
País: Brasil
Palavras-chave em Português:
Palavras-chave em Inglês:
Área do conhecimento CNPq:
Link de acesso: https://tede.unioeste.br/handle/tede/5827
Resumo: The present study aimed to evaluate the effects of increasing levels of inclusion in the diet of protein hydrolyzate composed of co-products of poultry and swine (giblets and liver) on the growth and stress resistance of Nile tilapia fry. For this purpose, 360 tilapia fingerlings with an average weight of 1.10 ± 0.07 g were used, randomly distributed in 24 polyethylene boxes (15 fish per box) with a capacity of 250 L, constituting six treatments with four replicates. The isoproteic and isoenergetic rations supplied until satiety five times a day, for 45 days and were formulated to contain 0.0; 0.3; 0.6; 0.9; 1.2 and 1.5% inclusion of hydrolyzed chicken protein (PHF) and hydrolyzed porcine liver protein (PHFS). At the end of the experimental period, the number of fish in each aquarium was counted and the weight and length of all individuals were measured to assess the influence of the hydrolyzate on zootechnical performance, where the parameters evaluated were the final weight, standard length final, specific growth rate, protein efficiency rate, condition factor and survival. The best hydrolyzate inclusion value obtained was 0.311% for final weight, 0.187% for final standard length, 0.205% for specific growth rate and 0.321% for protein efficiency rate, so as not to have influenced the condition factor and survival when compared to the control treatment, absent from the test ingredient.